MARKET

AWH

AWH

Aspira Womens Health Inc
NASDAQ
3.430
-0.070
-2.00%
After Hours: 3.430 0 0.00% 18:31 03/27 EDT
OPEN
3.500
PREV CLOSE
3.500
HIGH
3.510
LOW
3.300
VOLUME
24.76K
TURNOVER
0
52 WEEK HIGH
6.75
52 WEEK LOW
2.309
MARKET CAP
35.46M
P/E (TTM)
-1.6815
1D
5D
1M
3M
1Y
5Y
Pre-Market Earnings Report for March 28, 2024 : AFMD, ATAT, AWH, AZUL, CNF, DLNG, DOOO, DRIO, GROY, HUT, IMNN, ITRM
NASDAQ · 14h ago
A Preview Of Aspira Womens Health's Earnings
Aspira Womens Health is set to give its latest quarterly earnings report on Thursday, 2024-03-28. Analysts estimate the company will report an earnings per share of $-0.45. Last quarter the company beat EPS by $0.03, but shares are down 39.24%. Shares of Aspira womens health were trading at $3.5 as of March 26.
Benzinga · 19h ago
Aspira Women's Health Inc <AWH.OQ> expected to post a loss of 45 cents a share - Earnings Preview
Aspira Women's Health Inc expected to post a loss of 45 cents a share. The company is expected to report a 18.2% increase in quarterly revenue to $2.545 million. Wall Street's median 12-month price target for the company is $5.60.
Reuters · 1d ago
Weekly Report: what happened at AWH last week (0318-0322)?
Weekly Report · 2d ago
Aspira Women’s Health Updates CFO Compensation Agreement
TipRanks · 3d ago
Aspira Women’s Health Welcomes Sandra Milligan as President
TipRanks · 6d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
10 Bioscience (NASDAQ:YTEN) stock increased by 133.7% to $0.57 during Thursday's pre-market session. The company's market cap is at $5.2 billion. Immunovant and argenx stock moved upwards by 14.0% and 13.24% respectively. Losers Tourmaline Bio and Avinger stock decreased by 33.4% during the pre- market session.
Benzinga · 6d ago
Weekly Report: what happened at AWH last week (0311-0315)?
Weekly Report · 03/18 12:18
More
About AWH
Aspira Women's Health Inc. is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. Its products include Ova1, Overa, Ova1Plus and OvaWatch. Ova1 is a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician’s independent clinical and radiological evaluation does not indicate malignancy. Overa is a biomarker reflex intended to maintain Ova1's high sensitivity while improving specificity. Ova1Plus is a reflex offering, which uses Ova1 as the primary test and Overa as a confirmation for Ova1 intermediate range results. OvaWatch is a lab developed blood test intended to assist in the initial clinical assessment of malignancy risk in all women with an adnexal mass. The Company’s products are distributed through its own national sales force, through its decentralized testing platform.

Webull offers Aspira Women's Health Inc stock information, including NASDAQ: AWH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AWH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AWH stock methods without spending real money on the virtual paper trading platform.